About Us

Qlife is a medical device company that seeks to revolutionize the clinical biomarker market for whole blood testing by taking it out of the lab and into the homes. This will facilitate easy access to blood sample results and in turn facilitate increased monitoring of parameters that enables care improvement. Qlife Aps is owned by Qlife Holding AB in Sweden, who is currently seeking listing at Nasdaq, First North Growth Market, Stockholm, preliminarily as from 2 March 2020. Read more on Egoo.health, Qlifeholding.com or follow us on LinkedIn.